The drug is currently in human clinical trials as a standalone treatment. The first antibody, known as LNX-D09, protected mice from a lethal dose of whole venom from six of the snake species.

They identified two antibodies that neutralize venom from many different snake species with the aim of someday producing a treatment that could offer broad protection. It's very early research ...